Got $2,000? 1 Tech Infrastructure Monopoly to Buy and Hold for the Rest of Your Life

Photo of Alex Sirois
By Alex Sirois Published

Quick Read

  • ASML (NASDAQ: ASML) commands the only EUV lithography machines on earth, backed by a $45 billion backlog and 53% gross margins that lock in customers for decades.

  • ASML raised its dividend 17% and launched a €12 billion buyback program, funded by $13 billion in annual free cash flow.

  • Declining China sales and tightening export controls create near-term pressure, but no chipmaker can produce leading-edge chips without ASML tools.

  • Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and ASML didn't make the cut. Grab the names FREE today.

Got $2,000? 1 Tech Infrastructure Monopoly to Buy and Hold for the Rest of Your Life

© Intel

For an investor in their 50s or 60s who wants one technology holding that does not require monitoring, ASML Holding (NASDAQ:ASML | ASML Price Prediction) warrants long-term research attention because it is the only company on earth that manufactures the lithography machines required to print advanced chips, and that structural position compounds quietly regardless of which AI winner emerges.

It is a position designed to sit in a portfolio through multiple presidential administrations, multiple semiconductor cycles, and multiple technology paradigms.

Pillar 1: A Monopoly That Cannot Be Replicated

ASML is the sole global manufacturer of Extreme Ultraviolet (EUV) lithography machines, the building-sized systems required by TSMC, Samsung, Intel, and SK Hynix to produce advanced logic and memory chips. The competitive threat most often cited, xLight, remains in lab-stage and is targeting first silicon by 2028, while ASML has already shipped its first TWINSCAN EXE:5200B High NA EUV system. The year-end backlog of $45.06 billion represents customer commitments that take years to fulfill, locking foundry clients in through switching costs measured in decades.

Fundamentals reflect that moat. FY 2025 revenue reached $37.94 billion, net income hit $11.16 billion (+26.91% YoY), and gross margin came in at 52.8%. Q1 2026 EPS was $8.43, with operating margin of 36.0%.

Pillar 2: Compounding Through Dividends and Buybacks

ASML returns capital methodically. The 2025 total dividend of €7.50 per ordinary share represents a 17% increase versus 2024. Management also authorized a new €12 billion share buyback program effective January 28, 2026, to be executed by December 31, 2028, with approximately 0.9 million shares already repurchased for roughly €1.1 billion in Q1 2026. Free cash flow of $12.81 billion in 2025 funds both, and the Installed Base Management segment delivered $2.93 billion in Q1 2026, a recurring revenue stream that grows with every machine sold.

Pillar 3: Survival Across Cycles

Semiconductor demand is cyclical, while ASML’s relevance endures across cycles. The company posted losses during the dot-com bust (Q1 2002: -0.25 EPS) and the 2008-2009 financial crisis (Q1 2009: -0.27 EPS), then recovered and grew through both. By Q1 2026, EPS had reached 7.15 on the GAAP-reported basis. FY 2026 revenue is guided at €36 billion to €40 billion, and management has framed a 2030 opportunity of €44 billion to €60 billion at 56% to 60% gross margin.

The Scenario Where ASML Underperforms

The clearest near-term drag is geopolitical. China total net sales are expected to decline significantly in 2026 versus strong 2024 and 2025 levels, and proposed U.S. export legislation could pressure shipments further. A semiconductor downcycle paired with aggressive export controls would compress shipments. That scenario does not change the forever thesis. Customers cannot manufacture leading-edge chips without ASML tools, so deferred orders return to the backlog as a structural matter. The current P/E of 64 is rich, and patient buyers may prefer to scale in.

ASML fits a long-term, position-oriented thesis rather than a short-term trading framework.

Photo of Alex Sirois
About the Author Alex Sirois →

Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.

Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.

At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

SMCI Vol: 94,785,850
GLW Vol: 9,800,750
ON Vol: 6,247,213
ABBV Vol: 4,982,686
SWKS Vol: 3,094,613

Top Losing Stocks

CTRA Vol: 73,319,495
GEN Vol: 3,360,016
VRSN Vol: 806,084
MRNA Vol: 5,759,014
PLTR Vol: 36,397,509